Trending stocks today
Stan Wong
Director & Portfolio Manager at Private Wealth Management, ScotiaMcleod
Member since: Jun '09 · 2800 Opinions
Rating Card
| All | 
Rating
| 
Big Win
| 
Win
| 
Neutral
| 
Loss
| 
Big Loss
|  |
|---|---|---|---|---|---|---|---|
| 4.65 | 198 22.58% | 232 26.45% | 147 16.76% | 198 22.58% | 102 11.63% | ||
| 1 Month | 4.62 | 7 3.27% | 69 32.24% | 82 38.32% | 52 24.30% | 4 1.87% | |
| 6 Months | 4.81 | 34 16.59% | 71 34.63% | 36 17.56% | 52 25.37% | 12 5.85% | |
| 12 Months | 4.83 | 57 29.84% | 46 24.08% | 12 6.28% | 44 23.04% | 32 16.75% | |
| 2 Years | 4.74 | 57 33.73% | 36 21.30% | 14 8.28% | 34 20.12% | 28 16.57% | |
| 5 Years | 4.25 | 43 43.88% | 10 10.20% | 3 3.06% | 16 16.33% | 26 26.53% |
Stock Opinions by Stan Wong
He feels constructively optimistic about equity markets going forward. Inflation has been dropping for 9 consecutive months and will possibly continue into next year. Interest rates will stabilize and central banks will become much more dovish.
Historically when the Fed tightening cycle ends, 12 months later the S&P 500 is up an average of 14.3% with a win ratio of 80%. Despite volatility, markets are up since the October lows. We've had two 7%+ quarters. Those are signs of an uptrend.
N/A
Unknown
Likes the cyclical areas. Opportunities in financials, especially given what's happened in the last couple of months.
Despite oil being down, there are major constraints in supply, and demand remains steady. OPEC+ has reduced capacity and supply. Strategic petroleum reserve is down about 37% over the past couple of years. China's withdrawal from its zero-Covid policy is going to help names in the energy sector.
Consumer discretionary is his third most preferred area. Inflation dropping, China back on board after almost 3 years of lockdown.
Mostly defensive. In a rising, uptrending market, the names meander along sideways. Great for yield, however he prefers XEI. Enhanced yield of about 8.3%.
Adds cyclicals like financials and energy names to give you a bit more growth. Yield is 4.8%.
Chart shows bearish trendline channel since 2021 and underperforming the broader S&P 500. Technically, not strong. Massive competition from traditional automakers. Could lead to deceleration in sales growth, earnings, and margins. Expensive at 43x forward earnings.
Valuations are similar. CNR 200-day MA roughly sideways, the stock price is above that, average type of returns. CP's chart is fairly similar, but trending upwards a bit more. CP looks slightly better on technicals, so that's his choice.
Valuations are similar. CNR 200-day MA roughly sideways, the stock price is above that, average type of returns. CP's chart is fairly similar, but trending upwards a bit more. CP looks slightly better on technicals, so that's his choice.
On fire since late last year. Broken above the 200-day MA, which is rounding upwards. Only 18x forward earnings, price to sales is pretty cheap. Willing to pull back spending on the metaverse, which has helped the stock. Technically, looks positive, though he's uncertain if the trendline can continue.
Great opportunity, as it's trading below book value at 0.85x. Rising wages are a concern for every company. Benefited in deposits from smaller banks going under. Will see more share buybacks and dividend increases. Financials benefit from the early part of an economic cycle. Yield is 3.75%.
Still down massively from highs by about 67%. Cost-cutting is helpful, but valuation still expensive on all metrics. Stock is above the 200-day MA, seems to be basing. Overbought with today's news. Take some money off table.
Can't predict earnings performance report today. QCOM had tough numbers, mobile market is slowing. Not sure if that affects AAPL. Above 200-day MA, but that MA is still moving down. 6.6x price to sales, in line with the tech market, and not as expensive as some.
Still in his portfolio. Extremely strong renewal rates. Strong buying power. Still expecting 9-11% annualized earnings growth. Bit of a premium at 33x forward PE. Leadership name. Consumer staple, could do well in market softness.
Acquisitions have hampered stock price. Targets keep getting pushed our further. Lowered guidance. May be support levels around this price. Trades at 8x forward earnings, well below its historical 12.5x PE. Growth remains elusive. Dividend's great at 3.5%.
Wheat prices are coming down, then fertilizer prices become too much for farmers, and then demand comes down. Commodities in general are coming off highs. Longer term, likes the name, as product increases productivity. Volatile, pay attention if you trade.
Alzheimer's drug looks interesting, concerns about side effects. Good cancer drugs. Interesting diabetes and weight loss drug. 45x forward earnings, 20%+ growth rate. Pricey, be cautious. RSI at 79% is overbought. He owns MRK.
